Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences.
Quagliariello V, Rossetti S, Cavaliere C, Di Palo R, Lamantia E, Castaldo L, Nocerino F, Ametrano G, Cappuccio F, Malzone G, Montanari M, Vanacore D, Romano FJ, Piscitelli R, Iovane G, Pepe MF, Berretta M, D'Aniello C, Perdonà S, Muto P, Botti G, Ciliberto G, Veneziani BM, De Falco F, Maiolino P, Caraglia M, Montella M, Iaffaioli RV, Facchini G.
Quagliariello V, et al. Among authors: maiolino p.
Oncotarget. 2017 May 2;8(18):30606-30616. doi: 10.18632/oncotarget.16725.
Oncotarget. 2017.
PMID: 28389628
Free PMC article.
Review.